Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
J.F. Lehman & Company sells IGS to American Securities in strategic exit
J.F. Lehman & Company sells IGS to American Securities in strategic exit J.F. Lehman & Company (JFLCO) completed the sale of Integrated Global Services (IGS) to American Securities, marking the end of its successful investment in the asset integrity solutions...
Advent seeks $300m LBO loan for Ginko China acquisition amid Asia’s buyout boom
Advent seeks $300m LBO loan for Ginko China acquisition amid Asia’s buyout boom Advent International is in talks to secure a $300m leveraged buyout (LBO) loan to finance its acquisition of Ginko International’s mainland China operations. The financing, expected to be...
Private equity expands in radiology with over 150 acquisitions in a decade
Private equity expands in radiology with over 150 acquisitions in a decade Private equity investment in radiology has surged, with firms acquiring more than 150 radiology practices covering nearly 3,500 locations across the U.S. between 2013 and 2023, according to a...